In the upcoming years, the US generic drug market is anticipated to experience strong growth. The increasing cases of lifestyle diseases, initiatives undertaken by the US Government and upcoming patent expirations of branded drugs will contribute to the growth of the market.

According to the latest report by IMARC Group, the US generic drug market reached a value of nearly US$ 104 Billion in 2018, growing at a CAGR of more than 12% during 2011-2018.

Table of Contents

1   Preface

2   Scope and Methodology

3   Executive Summary

4   US Generic Drug Market - Introduction

5   Why is the US Generic Drug Market So Lucrative

6  Global Generic Drug Market

7   US Generic Drug Market

8   Market Breakup by Segment

9   Market Breakup by Therapy Area

10  Market Breakup by Drug Delivery

11  Market Breakup by Distribution Channel

12  US Generic Drug Market - SWOT Analysis

13  US Generic Drug Market - Value Chain Analysis

14  Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain

15  Porter’s Five Forces Analysis

16  US Generic Drug Market- Competitive Landscape

17  Regulations in the US Generic Drug Industry

18  US Generic Drug Market: Key Success Factors

19  US Generic Drug Market: Road Blocks

20  Requirements for Setting Up a Generic Drug Manufacturing Plant

21  US Generic Drug Market - Key Company Profiles

Source: US Generic Drug Market to Cross US$ 190 Billion by 2024​